GLP-2 TZ

Description

GLP-2 TZ is a dual-receptor research agonist targeting GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. The dual-agonist class has been characterized in the research literature for metabolic research, glucose-regulation research, and lipid-metabolism research. Nova supplies GLP-2 TZ across three lyophilized vial strengths: 10mg, 30mg, and 60mg in 3mL vials, and 100mg in a 10mL vial. All require reconstitution before research use. Every batch is triple-tested by an independent, ISO/IEC 17025-accredited laboratory. Every vial ships with a QR code linked to its batch Certificate of Analysis. For research use only. Not for human or animal consumption.